MADISON, Wis.--(BUSINESS WIRE)-- Roche NimbleGen (SWX:RO) (SWX:ROG) (Pink Sheets: RHHBY) today announced that one of New Zealand’s largest medical laboratories has adopted the NimbleGen CGX ...
This document was generated to support clinical cytogenetics laboratories in the testing and management of positive noninvasive prenatal screening (NIPS) results and is designed to be a rubric that ...
SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) today introduced three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal ...
MADISON, Wis. & WALTHAM, Mass.--(BUSINESS WIRE)-- Roche (SIX: RO, ROG; OTCQX: RHHBY) and PerkinElmer (NYSE: PKI) today announced a new supply agreement for distribution of the NimbleGen CGX microarray ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, announced today that the Applied Biosystems™ CytoScan™ Dx Assay and Applied Biosystems™ ...
Thermo Fisher Scientific, Inc. TMO recently launched the Applied Biosystems CytoScan HD Accel array — a new chromosomal microarray intended to enhance cytogenetic research lab productivity, efficiency ...
An international consortium of genetics experts has issued a consensus statement recommending chromosomal microarray (CMA) as the new standard practice for genetic evaluation of children with ...
New research shows that Optical Genome Mapping (OGM) detects abnormalities in chromosomes and DNA very quickly, effectively and accurately. Sometimes even better than all existing techniques together, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results